Inappropriate defibrillator shocks from depolarization - Repolarization mismatch in a patient with hypertrophy cardiomyopathy

PACE - Pacing and Clinical Electrophysiology

Volumn 30, Issue 11, 2007, Pages 1408-1411

  Kapa, Suraj ^a   Curwin, Jay H ^a,b   Coyne, Robert F ^a   Winters, Stephen L ^a  

^a MORRISTOWN MEMORIAL HOSPITAL   (United States)

^b Box 5 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; DEFIBRILLATOR; ECHOCARDIOGRAPHY; ELECTRODE; ELECTROGRAPHY; FOLLOW UP; HEART DEPOLARIZATION; HEART PACING; HEART REPOLARIZATION; HEART SEPTUM DEFECT; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMPLANTATION; MALE; SHOCK; SINUS RHYTHM; SYNCOPE; T WAVE;

ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHY, HYPERTROPHIC; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT FAILURE ANALYSIS; HUMANS; MALE; MIDDLE AGED; PROSTHESIS FAILURE;

EID: 35748961965     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2007.00881.x     Document Type: Article

References (11)

1. Scher DL. Troubleshooting pacemakers and implantable cardioverter- defibrillators. Curr Opin Cardiol. 2004 19: 36 46.
2. Passman R. Inappropriate implantable cardioverter defibrillator therapy in the short QT syndrome: Old problem in a new disease. J Cardiol Electrophys. 2003 14: 1278.
3. Przybylski A, Malecka L, Pytkowski M, Chojnowska L. Implantable cardioverter-defibrillators in patients with hypertrophic cardiomyopathy - Dilemmas and difficulties. Kardiol Pol. 2005 63: 391 397.
4. Freedman RA. Use of implantable pacemakers and implantable defibrillators in hypertrophic cardiomyopathy. Curr Opin Cardiol. 2001 16: 58 65.
5. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, et al., ACC/AHA/NASPE 2002 Guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002 106: 2145 2161.
6. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy;A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003 42: 1687 1713.
7. Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med. 2000 342: 365 373.
8. Atlee JL, Bernstein AD. Cardiac Rhythm Management Devices (Part 1): Indications, Device Selection, and Function. Anesthesiology. 2001 95: 1265 1280.
9. Weretka S, Michaelsin J, Becker R, et al. Ventricular oversensing: A study of 101 patients implanted with dual chamber defibrillators and two different lead systems. PACE 2003 26 (part I 65 70.
10. Hsu SS, Mohib S, Schroeder A, et al. T wave oversensing in implantable cardioverter defibrillators. J Interventional Cardiac Electrophysiology. 2004 11: 67 72.
11. Swerdlow CD, Friedman PA. Advanced ICD troubleshooting: Part I. Pacing Clin Electrophysiol. 2005 28: 1322 1346.